Paranasal sinus & nasal cavity lymphoma is a rare lymphoid malignancy originating from the lymphoid tissue of the nose or paranasal sinuses. Lymphoma is quite different from squamous cell carcinoma or adenocarcinoma, as it does not originate from the cells lining the nose but from lymphocytes, a type of white blood cell essential for the immune response.
Even though sinonasal lymphomas are rare, they tend to grow rapidly and can present with symptoms similar to chronic sinusitis, leading to delayed diagnosis. It is critical to have a quick evaluation done by our experts at the Head and Neck Oncology Department since sinonasal lymphoma is mainly treated with chemotherapy, immunotherapy, and radiation therapy.
The experienced oncologists, radiologists, pathologists, and other specialists at Tender Palm Hospital, Gomti Nagar, Lucknow, are committed to diagnosing and treating your lymphoma of the paranasal sinuses & nasal cavity.
Lymphoma of the sinus and nasal cavity is a malignant tumor arising from lymphocytes in the paranasal sinuses or nasal cavity. As lymphocytes are part of the body's immune system, lymphoma is a hematologic (blood- and lymphatics-related) cancer, even if it initially occurs in the nasal cavity or sinuses.
Unlike other types of sinonasal malignancies, lymphoma does not arise from the mucous membrane of the nose but is a disease of immune cells within nasal and sinus tissues.
Yes. Though lymphoma is a kind of blood malignancy, it is also considered a rare type of paranasal sinuses and nasal cavity cancer.
The diagnosis and treatment of this type of cancer differ greatly from those of squamous cell carcinoma or adenocarcinoma, which are more common, so it is important to diagnose lymphoma accurately.
Diffuse Large B-Cell Lymphoma is the most common B-cell lymphoma involving the nose and paranasal sinuses. It tends to grow rapidly but is responsive to current chemotherapy and immunotherapy.
It is a type of lymphoma that arises from either natural killer (NK) cells or T cells and is linked to infection with the Epstein-Barr virus. This condition usually affects the nasal cavity, and tissue necrosis may occur without proper treatment.
Less commonly, there may be involvement of the sinonasal tract with:
The specific subtype determines the treatment modality and prognosis.
The cause of sinonasal lymphoma is not completely known.
Lymphoma arises from abnormalities in lymphocytes, leading to uncontrolled proliferation and prolonged survival of these cells.
Some risk factors for this disease have been established:
However, most individuals do not have a definite cause for the condition.
The symptoms tend to be similar to those of chronic sinusitis, particularly at the early stage.
The usual symptoms are as follows:
There are other generalized symptoms of lymphoma, such as:
Such symptoms are also known as “B symptoms.”
ENT doctor is recommended if you suffer from the following symptoms:
Early detection enables treatment to commence before the disease becomes more complicated.
Diagnosis necessitates careful clinical assessment and lab investigations.
Your physician will evaluate your medical history, examine your head and neck region, and check for enlarged lymph nodes or any other indication of lymphoma.
An endoscope will enable your physician to visualize the tumor and take tissue samples.
To find out the stage of the condition, your doctor may recommend that you have:
PET-CT is especially useful because lymphomas often involve multiple regions of the body.
The tissue needs to be analyzed in order to diagnose sinonasal lymphoma.
The tests include:
They will help your doctor establish the lymphoma subtype.
Molecular testing, including EBER testing, might also be required in certain cases, particularly when there is suspicion of NK/T-cell lymphoma.
Bone marrow analysis could also be conducted in some patients to determine whether the lymphoma has metastasized.
The most common method of staging is the Lugano Classification, based on the Ann Arbor Staging System.
It is necessary to determine:
PET-CT is extremely important in staging and treatment planning.
The type of treatment depends on the lymphoma subtype, its stage, the patient's overall condition, and treatment preferences.
In contrast to other sinonasal malignancies, surgery usually has no role in treatment and is needed only for diagnostic biopsy.
The majority of sinonasal lymphomas are treated medically with chemotherapy.
Diffuse Large B-Cell Lymphoma is treated with a chemotherapy regimen in combination with immunotherapy.
Rituximab is an example of an immunotherapy agent, a monoclonal antibody specific for CD20-positive B cells, used with chemotherapy in eligible patients with B-cell lymphomas.
Radiation therapy can be used:
Certain individuals with either recurrent or high-risk lymphoma can be considered for autologous or allogeneic stem cell transplantation upon comprehensive assessment.
It is an individualized treatment decision-making by a multidisciplinary oncological team.
There are many patients with Sinonasal Lymphoma who can achieve a good response, long-term remission, or even a cure.
It largely depends on:
An early diagnosis has a very positive impact.
Prognosis depends on lymphoma type and stage.
Localized DLBCL has a very good prognosis with currently used chemoimmunotherapy.
Extranodal NK/T-cell lymphoma has a worse prognosis, but there is much improvement with currently available chemotherapy and radiotherapy.
Your oncologist can discuss your individual prognosis based on your diagnosis and reaction to the treatment.
Lymphoma left untreated may cause:
Treatment-induced side effects vary from case to case and are monitored throughout treatment.
The recovery process depends on the lymphoma subtype and the treatment administered.
The patient may require:
No. Lymphoma is cancer of the immune system cells, while most nasal cancers occur in the lining of the nasal cavity.
No. Surgery is only required for obtaining a biopsy. The patient is generally given chemotherapy, immunotherapy, radiotherapy, or a combination of these.
The most common B-cell lymphoma in the sinonasal region is Diffuse Large B-Cell Lymphoma (DLBCL), while the common aggressive T/NK-cell subtype in the nasal cavity is Extranodal NK/T-cell lymphoma.
Yes. Epstein-Barr virus is significantly associated with Extranodal NK/T-cell lymphoma, nasal type.
Yes. Lymphoma tends to metastasize to lymph nodes, bone marrow, and other organs if left untreated.
Yes. Despite the fact that the majority of patients enter remission, lymphoma may recur; therefore, long-term monitoring is necessary.
How often you need to be followed up will depend on the type of lymphoma you have and the therapy you receive, but it usually includes clinical examination, blood tests, and imaging studies in the first several years after treatment.
Tender Palm Super-Speciality Hospital offers advanced Lymphoma of the Paranasal Sinus & Nasal Cavity treatment in Lucknow, India, at an affordable cost. We have a team of experienced head and neck surgeons and hematology-oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including chemotherapy, radiation therapy, and comprehensive oncological management procedures. Our Head and Neck Surgery and Hematology-Oncology team has decades of experience in successfully treating Lymphoma of the Paranasal Sinus & Nasal Cavity in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com